Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Qingdao Health Ocean Biopharmaceutical Co. Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single case is assigned to 1 distinct examiner and 1 distinct art unit. The narrow scope of this activity indicates a targeted approach to its current patent prosecution, with all efforts concentrated in one administrative sector.
The busiest examiner, SHIAO, YIH-HORNG, is handling 1 pending office action, which accounts for the entire active portfolio. With only 1 distinct art unit involved, the company's immediate patent prospects are concentrated in one specific regulatory channel. Practitioners should focus on the specific examination history and preferences of SHIAO, YIH-HORNG to navigate this single pending action successfully within the Biotechnology & Pharmaceuticals field.
Because the busiest examiner, SHIAO, YIH-HORNG, is responsible for the 1 pending office action, there is no internal data to compare examiner behavior. The presence of 1 distinct examiner and 1 distinct art unit creates a high-stakes environment where the outcome depends on a single official's interpretation. Strategy must be precisely aligned with the standards of this specific art unit to ensure a favorable result for the company.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIAO, YIH-HORNG | 1 | 72.5% | +75.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18286989 | THIOLATED POLYSACCHARIDE DERIVATIVE HYDROGEL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | SHIAO, YIH-HORNG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18286989 | THIOLATED POLYSACCHARIDE DERIVATIVE HYDROGEL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | SHIAO, YIH-HORNG | — |
| Art Unit | Apps |
|---|---|
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18286989 | THIOLATED POLYSACCHARIDE DERIVATIVE HYDROGEL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | SHIAO, YIH-HORNG | 1691 | §102§103§112Other | Non-Final OA | — | Pending | Oct 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial